TVGN insider buying and SEC filings, explained
Tevogen Inc. · CIK 1860871
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq, Nasdaq
- Industry (SIC)
- Biological Products, (No Diagnostic Substances)
- State of incorporation
- DE
- Fiscal year end
- Dec 31
- Former names
- Tevogen Bio Holdings Inc.; Semper Paratus Acquisition Corp
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$7K
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Mar 10–13, 2026 | Sale | Neal Flomenberg (Chief Scientific Officer) sold 972 shares between Mar 10 and Mar 13 at about $6.83 ($7K). Holdings down 1% to 76,940 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 17, 2026 |
17 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Nov 2, 2026, 5:31 PM ET 8-K | Material agreement (Item 1.01) New debt or obligation (Item 2.03) Unregistered share sale (Item 3.02) Executive or director change (Item 5.02) | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow TVGN in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.